Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment

expresspharmaSeptember 22, 2020

Tag: BDR Pharma , Prostate Cancer , enzalutamide , mCRPC

PharmaSources Customer Service